Macular oedema: the measurements that count

Article

Thickness measurements of the central macular region can be used to differentiate between eyes with and without diffuse clinically significant macular oedema (CSMO), but not between eye with or without foveal CSMO, according to a study published in the February issue of Acta Ophthalmologica Scandinavia.

Thickness measurements of the central macular region can be used to differentiate between eyes with and without diffuse clinically significant macular oedema (CSMO), but not between eye with or without foveal CSMO, according to a study published in the February issue of Acta Ophthalmologica Scandinavia.

Lars Loumann Knudsen from the Aarhus University Hospital, Aalborg, Denmark, conducted a study that included 47 normal subjects and 158 ocular examinations of 38 eyes from 22 diabetic subjects with and without CSMO. The central macular region was subdivided into narrow concentric rings around the foveola and the thickness of the individual concentric rings were calculated. Sensitivity and specificity of the CSMO diagnosis were established using the average thickness and the thickness of the concentric rings.

It was found that the average thickness of the central macular region was 165.1 µm in the normal subjects and 192.3 µm in eyes without CSMO. The thickness increased significantly to 198.2 µm in eyes with foveal CSMO and 236.9 µm in eyes with diffuse CSMO. Sensitivity for focal CSMO was 48% with average thickness measurements and 83.6% with concentric rings. The corresponding values for detection of diffuse CSMO were 91.7% and 96.1%, respectively. Specificity was 77.4% with average thickness measurements and 79.7% with concentric rings.

Knudsen concluded that, although thickness measurements can be used to distinguish between eyes with and without diffuse CSMO, it is not as effective at distinguishing between eyes with and without foveal CSMO. He added that sub–analysis based on concentric rings around the foveola does seem to be a useful clinical tool for increasing diagnostic certainty.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
© 2025 MJH Life Sciences

All rights reserved.